Shooting the Gaps

02/22/2005

Zeke Ashton and his Centaur Capital Partners’ colleague Matthew Richey share their thoughts on why value investors often underestimate business quality, where market perceptions are lagging reality – both long and short – and why they are particularly interested right now in Laboratory Corp. of America and Shimano. 


If you are a subscriber, log in to access the issue and bonus archive:


Not a subscriber? Subscribe today!